search
Back to results

Biofeedback Rehabilitation to Improve Speaking and Eating in Public (Biofeedback)

Primary Purpose

Oral Cavity Squamous Cell Carcinoma

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Electropalatography Biofeedback Training
Sponsored by
University Health Network, Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Oral Cavity Squamous Cell Carcinoma focused on measuring Oral Cavity Squamous Cell Carcinoma, Biofeedback, Rehabilitation, Head and Neck Cancer, electropalatography, EPG

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Oral cavity carcinoma involving the tongue or floor of the mouth
  • Primary surgical treatment or/
  • Primary surgical treatment with adjuvant radiation therapy or/
  • Salvage surgical treatment
  • At least 2 weeks post treatment

Exclusion Criteria:

  • Anatomic palate abnormality that precludes fitting a mouthpiece
  • Cognitively unable to participate in biofeedback
  • Persistent Cancer
  • Does not speak English

Sites / Locations

  • University Health NetworkRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Self-Directed Tongue Strengthening Rehab

SLP Directed Face-to-Face Rehab

Arm Description

8 sessions of self-directed tongue strengthening exercises followed by 8 sessions of electropalatography biofeedback training. Assessments will be taken during the beginning, middle, and end of each study arm.

8 sessions of SLP-directed face-to-face rehabilitation program followed by 8 sessions of electropalatography biofeedback training. Assessments will be taken during the beginning, middle, and end of each study arm.

Outcomes

Primary Outcome Measures

Change in Percent Intelligibility of Speech Over 4 Months
Change in percent intelligibility is measured using Assessment of Intelligibility of Dysarthric Speech (AIDS). Assessment of Intelligibility of Dysarthric Speech (AIDS) is a validated tool that is used in this outcome to measure intelligibility as compared with normal subjects for quantifying single-word intelligibility and sentence intelligibility.
Change in Rate of Intelligible Speech Over 4 Months
Change in intelligibility rate is also measured using Assessment of Intelligibility of Dysarthric Speech (AIDS). Assessment of Intelligibility of Dysarthric Speech (AIDS) is a validated tool that is used in this outcome to measure speed of language as compared with normal subjects for quantifying speaking rate.
Change in Speech Acceptability Over 4 Months
Assessment of Speech Acceptability is a qualitative measure of "conversational understandability" of language as compared with normal subjects. Subjects will be given 6-word sentences to read where five naïve listeners will evaluate the speakers' speech acceptability on a scale of 4. This is a subsection of the AIDS test.
Change in Speech and Swallowing Over 4 Months
This is a disease specific, 6-item, administered questionnaire to evaluate post-treatment speech and swallowing ability measure will provide critical data on the socialization of the patient as it relates to speaking and eating.

Secondary Outcome Measures

Change in Patient Satisfaction of EPG Biofeedback Over 4 Months
The patient will be given a self-administered questionnaire to assess satisfaction and adoption of biofeedback.
Difference in Cost for Intervention versus Standard of Care Over Time
Hospital, personnel and patient cost will be collected. SLP time will be recorded on time sheets. The fuel and parking cost will be imputed based on the first 3 numbers of the postal code.

Full Information

First Posted
May 29, 2018
Last Updated
May 31, 2022
Sponsor
University Health Network, Toronto
search

1. Study Identification

Unique Protocol Identification Number
NCT03650699
Brief Title
Biofeedback Rehabilitation to Improve Speaking and Eating in Public
Acronym
Biofeedback
Official Title
Rehabilitation of Head and Neck Cancer Patients With Biofeedback Training to Improve Speaking and Eating in Public
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 28, 2018 (Actual)
Primary Completion Date
December 1, 2022 (Anticipated)
Study Completion Date
December 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Tongue cancer requires resection and reconstruction that can leave patients disabled with respect to speaking and eating. Impairment of tongue function can have significant impact on social interaction and employment. To try and improve speaking and eating in public, the team at the University Health Network is going to use a special device that is designed to help the patient rehabilitate after tongue cancer treatment. The research part of this study is to use a special mouthpiece or mold that is like a partial plate for upper dentures that will fit on the roof of the mouth. This mold is embedded with 62 sensors that will allow patients to visualize their tongue position during speech. With the help of a speech therapist, patients can learn different tongue positions important speaking and eating. This whole process is called biofeedback. The visualization of the tongue gives the patient the flexibility to practice at home to and learn different tongue positions important to eating and speaking. In addition, the device will provide the speech pathologist with an opportunity for easier and more precise assessment of the patient's progress which can reduce the need for visits to the hospital. The investigators expect the biofeedback training to improve the patient's speaking and eating. The study hypothesis is that the biofeedback device will improve speech intelligibility, eating in public, speaking in public, and oral intake scores.
Detailed Description
Subjects will be enrolled in either arm of the study for duration of 4 months. Patients that are randomized into study arm 1 will come to the clinic for Speech Language Pathologist (SLP) directed face-to-face rehabilitation for a period of 2 months. The patients will then transition to participate in weekly face-to-face Electropalatography (EPG) biofeedback training. The EPG biofeedback will be used for 2 months. Patients that are randomized into study arm 2 will first undergo a self-directed tongue strengthening program (oral exercises) for a period of 2 months and then transition into EPG biofeedback training. Although randomization will be used, this is a nonstandard trial because all patients will receive biofeedback EPG. Patients from both study arms will receive biofeedback training after undergoing an SLP directed face-to-face rehabilitation program versus a self-directed tongue strengthening program (oral exercises). The SLP directed face-to-face rehabilitation program or self-directed tongue strengthening program will be initiated at least 2 weeks post-surgery. If the patient is treated with adjuvant radiation, the patient will take a self-directed biofeedback holiday with a target of restarting at least 2 after the completion of adjuvant treatment. This design was chosen because there is equipoise with respect to the efficacy of the intervention and uncertainty with respect to whether the intervention is most valuable following an SLP directed face-to-face rehabilitation program versus a self-directed tongue strengthening program. The design offers all patients the opportunity to participate in the intervention. This approach will also allow us to analyze between subject change and within subject change. The A.I.D.S assessment has been in place for approximately 50 years. The mean A.I.D.S. efficiency score (95%CI) in the current pilot study (n=16) is 0.54 (46.0, 62.3). With 33 patients in each group, there will be over 80% power to detect a 10% difference in the speech efficiency score even under the condition that there may be low (rho<0.1) correlation within subject. Higher correlation within subject on the various scores would serve to increase the efficiency of the analysis. Bivariate comparison will be made between the arms with respect to the primary and secondary outcome variables at each time point. Linear mixed model will be used to account for multiple measures at multiple time points. The first step will be to compare arms with respect to the primary and secondary outcome variables. For those tests that are significant a backward selected regression will be performed to control for confounders and to look for important effect modifier variables. Variables related to rehabilitation participation will be modeled in the backward selected regression.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oral Cavity Squamous Cell Carcinoma
Keywords
Oral Cavity Squamous Cell Carcinoma, Biofeedback, Rehabilitation, Head and Neck Cancer, electropalatography, EPG

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
66 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Self-Directed Tongue Strengthening Rehab
Arm Type
Experimental
Arm Description
8 sessions of self-directed tongue strengthening exercises followed by 8 sessions of electropalatography biofeedback training. Assessments will be taken during the beginning, middle, and end of each study arm.
Arm Title
SLP Directed Face-to-Face Rehab
Arm Type
Experimental
Arm Description
8 sessions of SLP-directed face-to-face rehabilitation program followed by 8 sessions of electropalatography biofeedback training. Assessments will be taken during the beginning, middle, and end of each study arm.
Intervention Type
Device
Intervention Name(s)
Electropalatography Biofeedback Training
Intervention Description
The study agent is electropalatography (EPG). The LinguaGraph EPG device is a biofeedback technology that creates a digital visualization of tongue function during speech. The visualization is accomplished by a custom made mouthpiece that fits over the hard palate with 62 sensors that capture tongue position. The information from the sensors in the mouthpiece, as well as the audio output, is processed in an EPG Unit that converts the information from mouthpiece to a visual representation on a computer screen. The visual information with respect to tongue position can be used to provide biofeedback training.The computer can be used in the clinic during a patient visit or it can be seen over the internet with the patient at home and the speech and language pathologist at the clinic.
Primary Outcome Measure Information:
Title
Change in Percent Intelligibility of Speech Over 4 Months
Description
Change in percent intelligibility is measured using Assessment of Intelligibility of Dysarthric Speech (AIDS). Assessment of Intelligibility of Dysarthric Speech (AIDS) is a validated tool that is used in this outcome to measure intelligibility as compared with normal subjects for quantifying single-word intelligibility and sentence intelligibility.
Time Frame
Administered at 0, 2, and 4 months
Title
Change in Rate of Intelligible Speech Over 4 Months
Description
Change in intelligibility rate is also measured using Assessment of Intelligibility of Dysarthric Speech (AIDS). Assessment of Intelligibility of Dysarthric Speech (AIDS) is a validated tool that is used in this outcome to measure speed of language as compared with normal subjects for quantifying speaking rate.
Time Frame
Administered at 0, 2, and 4 months
Title
Change in Speech Acceptability Over 4 Months
Description
Assessment of Speech Acceptability is a qualitative measure of "conversational understandability" of language as compared with normal subjects. Subjects will be given 6-word sentences to read where five naïve listeners will evaluate the speakers' speech acceptability on a scale of 4. This is a subsection of the AIDS test.
Time Frame
Administered at 0, 2, and 4 months
Title
Change in Speech and Swallowing Over 4 Months
Description
This is a disease specific, 6-item, administered questionnaire to evaluate post-treatment speech and swallowing ability measure will provide critical data on the socialization of the patient as it relates to speaking and eating.
Time Frame
Administered at 0, 2, and 4 months
Secondary Outcome Measure Information:
Title
Change in Patient Satisfaction of EPG Biofeedback Over 4 Months
Description
The patient will be given a self-administered questionnaire to assess satisfaction and adoption of biofeedback.
Time Frame
Administered time 0, 2, and 4 months
Title
Difference in Cost for Intervention versus Standard of Care Over Time
Description
Hospital, personnel and patient cost will be collected. SLP time will be recorded on time sheets. The fuel and parking cost will be imputed based on the first 3 numbers of the postal code.
Time Frame
Weekly, Up to 16 Weeks
Other Pre-specified Outcome Measures:
Title
Measure of Obliteration using Oral Volume Assessment Tool (OVAT)
Description
Obliteration of the oral cavity is defined as the ability of the tongue volume to obliterate the oral cavity so that there is space between the tongue and the hard and soft palate. Obliteration is measured using the Oral Volume Assessment Tool (OVAT) which is a measure of displacement. This is an important mechanism of bolus propulsion during the oral phase of swallowing.
Time Frame
Administered at 0, 2, and 4 months
Title
Measure of Tongue Protrusion
Description
Protrusion of the tongue is defined as the distance the tongue can be extended beyond the central mandibular incisors measured in millimeters. This is important for the finger function of the tongue.
Time Frame
Administered at 0, 2, and 4 months
Title
Measure of Tongue Elevation
Description
Elevation of the tongue is defined as distance the tongue can be moved superiorly above the central mandibular incisors measured in millimeters. The goal is to obtain premaxillary contact.
Time Frame
Administered at 0, 2, and 4 months
Title
Fiberoptic Endoscopic Evaluation of Swallow (FEES)
Description
FEES is an assessment that involves placing a flexible endoscope transnasally to obtain a superior view of the pharynx and larynx. The purpose is to evaluate structure & function of the upper aerodigestive tract. This assessment enables visualization nasopharynx, base of the tongue, oropharynx, hypopharynx, and larynx. FEES is used for assessment of retained secretions and retained food consistencies. It is useful for assessing airway protection as it relates to swallowing function. After assessment, FEES is useful for evaluation of the effectiveness of compensatory techniques (postures, maneuvers, bolus modifications) for improving swallowing safety and efficiency. This is a standard of care assessment but is not routinely performed on all OCSCC patients. The surgeon/SLP will use FEES to look at swallowing function and the effectiveness of rehabilitation.
Time Frame
Administered time 0, 2, and 4 months
Title
Clinical Speech and Language Assessment
Description
This is documentation of data that would appear in a clinical speech and language consultation. There are parts of the assessment that cannot be performed if the patient does not return to the hospital and the consultation is performed with a video link. These sections of the assessment will be marked "missing data" on the data sheet.
Time Frame
Weekly, Up to 16 weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Oral cavity carcinoma involving the tongue or floor of the mouth Primary surgical treatment or/ Primary surgical treatment with adjuvant radiation therapy or/ Salvage surgical treatment At least 2 weeks post treatment Exclusion Criteria: Anatomic palate abnormality that precludes fitting a mouthpiece Cognitively unable to participate in biofeedback Persistent Cancer Does not speak English
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Daniella De Dios, BACYC
Phone
416-340-3082
Email
daniella.dedios@uhn.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Douglas Chepeha, MD
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Health Network
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 2C4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daniella De Dios, BACYC
Phone
416-340-3082
Email
daniella.dedios@uhn.ca

12. IPD Sharing Statement

Learn more about this trial

Biofeedback Rehabilitation to Improve Speaking and Eating in Public

We'll reach out to this number within 24 hrs